GL Pharm Tech Calls Shareholders Meeting for 5:1 Reverse Stock Split and Article Amendment
GL Pharm Tech will hold an extraordinary shareholders' meeting on July 6, 2026 to vote on a 5:1 reverse stock split and amendment to articles of incorporation.
The reverse split changes the par value from 100 won to 500 won per share, reducing outstanding shares from 77,549,006 to 15,509,801 without altering total equity.
The action aims to stabilize the stock price and enhance corporate value; capital stock remains nearly unchanged at 7,754,900,500 won after rounding.
The meeting also covers management reference items including a 20 million won loan to subsidiary GLP Pharma representing 6.52% of assets.
Independent directors received total compensation of 17,235 won with 100% board attendance.
[AI Summary]This shareholders' meeting proposes a non-dilutive reverse stock split and routine article amendments focused on stock price stabilization. With no capital changes or governance shifts, the event is neutral for shareholder value and has limited short-term price impact.